Inspire — formally known as hypoglossal nerve stimulation — has been one of the most marketed alternatives to CPAP since its FDA approval in 2014. The TV ads promise "no mask, no hose, no machine," which makes the comparison sound like a no-brainer for anyone who's struggled with CPAP. The reality is more nuanced. Inspire is genuinely effective for a specific subset of patients, but the eligibility is strict, the surgery is real, and the trade-offs are worth understanding before deciding it's the answer to your therapy.
The short answer
Inspire works well for the right patient — typically a person with moderate-to-severe OSA (AHI 15-65), BMI under 32, and specific airway anatomy verified by drug-induced sleep endoscopy. For that population, AHI reductions of 70%+ are common. Inspire is not a good fit if your BMI is over 32, your AHI is over 65, or your airway collapses in a concentric pattern. CPAP remains the right answer for ~85% of OSA patients.
What Inspire actually is
Inspire is a small implanted device — about the size of a pacemaker — placed under the skin of your chest, with a sensor lead in your rib cage and a stimulator lead routed up to the hypoglossal nerve in your neck. The hypoglossal nerve controls the tongue. When the sensor detects you trying to inhale, the stimulator pulses the nerve, which contracts the tongue muscles, which pulls the tongue forward and opens the airway.
You turn it on at bedtime with a small remote and turn it off in the morning. No mask, no hose, no humidifier, no power cable. The device runs on an internal battery that lasts 10-11 years before requiring surgical replacement.
Who Inspire is for
Eligibility is relatively strict:
- Adult (18+). Pediatric versions exist for specific genetic conditions but aren't part of the standard adult workflow.
- Moderate-to-severe OSA — AHI between 15 and 65.
- BMI under 32 (some surgeons accept up to 35). The mechanism relies on tongue position changing airway geometry — fat tissue beyond the tongue itself reduces efficacy.
- Documented inability to tolerate CPAP. Insurance requires proof you genuinely tried — usually 90+ days of attempted CPAP with poor compliance documented by the machine.
- Non-concentric airway collapse on drug-induced sleep endoscopy. A concentric pattern (the airway collapses in a ring) doesn't respond well to tongue stimulation — only ~30% of evaluated patients have a favorable pattern.
How effective is it
The pivotal STAR trial (NEJM, 2014) showed:
- 68% reduction in AHI at 12 months (from a median of 29 events/hour down to 9 events/hour).
- 66% of patients reached AHI < 15 (moved from severe to mild range or normal).
- 42% reached AHI < 5 (the clinical normal threshold — the patients in this subset effectively no longer had OSA on therapy).
Five-year follow-up data has been broadly consistent — durability of effect is good. The device doesn't lose effectiveness over time the way some surgical interventions do.
For comparison: well-treated CPAP achieves AHI < 5 in 70-80% of compliant users. CPAP is more effective on average; Inspire is meaningfully effective and more comfortable for the patients who can't make CPAP work.
What the surgery actually involves
Inspire is implanted in a single outpatient procedure under general anesthesia, usually 2-3 hours. Three incisions:
- A 3-inch incision on the right side of your chest, just below the collarbone, for the generator/battery (similar to a pacemaker).
- A 1-inch incision on the right side of your neck, for the stimulator lead to the hypoglossal nerve.
- A 1-inch incision on your right rib cage, for the breathing-sensor lead.
Recovery: usually back to non-strenuous work within 2-3 days, full activity in about 3 weeks. The device is activated about a month after surgery to let tissues heal first. Then there's a 1-2 month titration period where you and your sleep doctor adjust stimulation settings.
Cost and insurance
Inspire is FDA-approved and covered by Medicare and most major commercial insurance plans for eligible patients. Out-of-pocket cost varies enormously:
- With full insurance coverage: $0 to a few thousand dollars, depending on your deductible.
- Without insurance: $30,000-50,000 list price, though most surgeons negotiate cash-pay rates.
Getting through the insurance prior-authorization process typically takes 2-4 months and requires documentation of failed CPAP, your AHI, BMI, sleep endoscopy, and a referral from a sleep specialist.
The real trade-offs
TV ads don't mention these. They're worth knowing.
You can't have MRI scans easily
Inspire is MRI-conditional — meaning specific MRI machines and protocols are safe, but not all of them. Older 1.5T machines often work; newer 3T machines may not. If you anticipate needing MRIs (cancer history, cardiac issues, joint problems, etc.), this is a meaningful constraint.
Tongue soreness
About 25% of Inspire users report mild tongue soreness or fatigue in the first few months. It usually resolves but sometimes persists. The tongue is being contracted hundreds of times per night.
It doesn't help central apnea
Inspire only addresses obstructive events. If you have mixed or central apnea, Inspire won't help with the central component and may be inappropriate.
The remote is annoying for some users
You have to remember to turn it on at bedtime. If you forget, it doesn't run. Some users find this less hassle than CPAP; others find the remote routine about equivalent to wearing a mask.
It can fail or migrate
Rare but real: leads can shift over time, requiring re-implantation surgery. Reported lead-related complications at 5 years: about 4-6%. Replacement of the battery generator after 10-11 years is essentially guaranteed.
How it compares to CPAP, fairly
| CPAP | Inspire | |
|---|---|---|
| Effectiveness | AHI < 5 in 70-80% of compliant users | AHI < 5 in 42%, AHI < 15 in 66% |
| Compliance rate | ~60% at 1 year (the actual problem) | ~94% (much less burden) |
| Upfront cost | $800-1500 (machine + mask) or insurance copay | $30-50k surgery, usually insurance-covered |
| Ongoing cost | ~$50/mo for replacement supplies | ~$0 until battery replacement at year 10-11 |
| Comfort | Mask, hose, machine on nightstand | Nothing visible — implanted |
| Travel | Bring machine | Bring remote (smaller than a phone) |
| Recovery | 1-3 nights to acclimate | 3 weeks after surgery + titration period |
| Reversible | Yes, instantly | Requires surgery to remove |
| Works for severe OSA (AHI > 65) | Yes | Generally no |
| Works for high BMI | Yes | BMI < 32 (sometimes 35) |
The honest decision framework
Ask yourself three questions in order:
- Have you genuinely tried CPAP for 90+ days with the right mask and settings? If no, you're not eligible for Inspire by insurance criteria anyway, and most CPAP failures resolve when therapy is properly tuned — the first 90 days and leak troubleshooting together fix most cases.
- Do you meet the strict Inspire criteria?AHI 15-65, BMI < 32, non-concentric collapse. If you fail any of these, Inspire isn't your answer.
- Are you comfortable with implant surgery and MRI restrictions? Inspire is real surgery with real recovery and real long-term constraints. For patients deeply distressed by CPAP and clinically eligible, this trade-off is worth it. For patients merely annoyed by CPAP, it usually isn't.
If CPAP has been frustrating you, the cheapest experiment is to fix what's broken in your current setup before jumping to surgical alternatives. Most CPAP misery traces to a worn cushion, wrong mask style, or untuned pressure. Read why your mask isn't sealing and CPAP side effects — those two articles cover 80% of "I hate CPAP" reasons.
Bottom line
Inspire is a real, FDA-approved alternative to CPAP for a specific subset of OSA patients. It works well for the people who qualify. The pre-surgery hurdles (eligibility criteria, insurance authorization, drug-induced sleep endoscopy) exist for good reason — patients outside the eligibility window genuinely don't get the same outcomes. For the majority of OSA patients, CPAP — well-fitted, well-tuned, with on-cadence supply replacement — is still the right answer.